NCT07104383Phase 3Active not recruiting

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Study sponsor: Viking Therapeutics, Inc. · VKTX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-07-01Estimated
Enrollment · participants1100Estimated
Source updated2026-04-07Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source